| 1 |
Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage.
62
|
Appeltshauser L...Doppler K
|
36346134 |
2022 |
| 2 |
Campylobacter jejuni and Postinfectious Autoimmune Diseases: A Proof of Concept in Glycobiology.
62
|
Stein RA
|
36137262 |
2022 |
| 3 |
Potential therapeutic strategies in chronic inflammatory demyelinating polyradiculoneuropathy.
62
|
Hu J...Lin J
|
34999243 |
2022 |
| 4 |
Guillain-Barre syndrome in Mexico: clinical features and validation of Brighton Collaboration Group criteria.
62
|
Lopez-Hernandez JC...Vargas-Canas ES
|
35383873 |
2022 |
| 5 |
IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality.
62
|
Fehmi J...Rinaldi S
|
34400540 |
2021 |
| 6 |
Guillain-Barré Syndrome and Other Acute Polyneuropathies.
62
|
Kwan J...Biliciler S
|
33858613 |
2021 |
| 7 |
Inhibition of TLR4 signaling protects mice from sensory and motor dysfunction in an animal model of autoimmune peripheral neuropathy.
62
|
Oladiran O...Zhang J
|
33752705 |
2021 |
| 8 |
Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathy.
62
|
Jhaveri KS...Rapoport AP
|
33284942 |
2020 |
| 9 |
Toxemia in Human Naturally Acquired Botulism.
62
|
Rasetti-Escargueil C...Popoff MR
|
33202855 |
2020 |
| 10 |
Screening for genetic mutations in patients with neuropathy without definite etiology is useful.
62
|
Vogt B...Karam C
|
32399692 |
2020 |
| 11 |
Antiparanodal antibodies and IgG subclasses in acute autoimmune neuropathy.
62
|
Appeltshauser L...Doppler K
|
32736337 |
2020 |
| 12 |
Adjuvant rituximab improves sensory ataxia in CIDP-related Sjögren syndrome.
62
|
Rocha R...Martins J
|
32847874 |
2020 |
| 13 |
Campylobacter Abundance in Breastfed Infants and Identification of a New Species in the Global Enterics Multicenter Study.
62
|
Bian X...Szymanski CM
|
31941810 |
2020 |
| 14 |
On-Membrane Dynamic Interplay between Anti-GM1 IgG Antibodies and Complement Component C1q.
62
|
Yanaka S...Kato K
|
31878295 |
2019 |
| 15 |
Amphiphysin-IgG autoimmune neuropathy: A recognizable clinicopathologic syndrome.
62
|
Dubey D...Klein CJ
|
31624089 |
2019 |
| 16 |
Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy.
62
|
Stengel H...Doppler K
|
31454780 |
2019 |
| 17 |
Varicella Zoster Virus Encephalitis Mimicking Nivolumab-Induced Autoimmune Neuropathy in a Patient with Lung Cancer.
62
|
Watanabe Y...Aoshiba K
|
31345336 |
2019 |
| 18 |
Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.
62
|
Belmokhtar C...Pouget J
|
30903535 |
2019 |
| 19 |
High salt diet ameliorates functional, electrophysiological and histological characteristics of murine spontaneous autoimmune polyneuropathy.
62
|
Huehnchen P...Endres M
|
30468863 |
2019 |
| 20 |
Intravenous immunoglobulins for rheumatic disorders and thromboembolic events-a case series and review of the literature.
62
|
Lidar M...Levy Y
|
30565202 |
2018 |
| 21 |
Extremely Painful Multifocal Acquired Predominant Axonal Sensorimotor Neuropathy of the Upper Limb.
62
|
Lieba-Samal D...van Alfen N
|
29159899 |
2018 |
| 22 |
IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4+ T Cell Migration.
62
|
Smith CJ...Su MA
|
29367208 |
2018 |
| 23 |
Acute painful autoimmune neuropathy: A variant of Guillain-Barré syndrome.
62
|
Yuki N...Wilder-Smith E
|
28667708 |
2018 |
| 24 |
Gangliosides and Autoimmune Peripheral Nerve Diseases.
62
|
Goodfellow JA...Willison HJ
|
29747820 |
2018 |
| 25 |
Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.
62
|
Burnor E...Lancaster E
|
29187518 |
2018 |
| 26 |
Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.
62
|
Dubey D...Klein CJ
|
29222126 |
2018 |
| 27 |
[Bickerstaff's encephalitis].
62
|
Elchaninov AP...Grishchenkov AS
|
30132464 |
2018 |
| 28 |
Nodes, paranodes and neuropathies.
62
|
Fehmi J...Rinaldi S
|
28819062 |
2018 |
| 29 |
Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.
62
|
Brooks PT...Mansfield LS
|
28789710 |
2017 |
| 30 |
Microarray screening of Guillain-Barré syndrome sera for antibodies to glycolipid complexes.
62
|
Halstead SK...Willison HJ
|
27790627 |
2016 |
| 31 |
[Chronic Inflammatory Demyelinating Polyneuropathy].
62
|
Balke M...Lehmann HC
|
27951607 |
2016 |
| 32 |
Terminal complement activation is increased and associated with disease severity in CIDP.
62
|
Quast I...Lunemann JD
|
27648461 |
2016 |
| 33 |
Complete neurologic and cognitive recovery after plasmapheresis in a patient with chronic inflammatory demyelinating polyneuropathy after allogeneic hematopoietic stem cell transplantation.
62
|
Vogl U...Schulenburg A
|
26919852 |
2016 |
| 34 |
Anti-Ganglioside Antibodies Induce Nodal and Axonal Injury via Fcγ Receptor-Mediated Inflammation.
62
|
He L...Sheikh KA
|
25926454 |
2015 |
| 35 |
Toll-like receptors recognize distinct proteinase-resistant glycoconjugates in Campylobacter jejuni and Escherichia coli.
62
|
Phongsisay V...Fujimoto S
|
25530156 |
2015 |
| 36 |
3-O-sulfo-β-D-galactose moiety of endogenous sulfoglycolipids is a potential ligand for immunoglobulin-like receptor LMIR5.
62
|
Phongsisay V...Yamasaki S
|
25172093 |
2015 |
| 37 |
Corneal sensitivity in chronic inflammatory demyelinating polyneuropathy.
62
|
Bansal S...Patel SP
|
24858016 |
2014 |
| 38 |
Contrasting immune responses mediate Campylobacter jejuni-induced colitis and autoimmunity.
62
|
Malik A...Mansfield LS
|
24220299 |
2014 |
| 39 |
[Diabetes mellitus and autoimmune neuropathy].
62
|
Deguchi T...Takashima H
|
24523312 |
2014 |
| 40 |
Fcγ receptor-mediated inflammation inhibits axon regeneration.
62
|
Zhang G...Sheikh KA
|
24523933 |
2014 |
| 41 |
Intravenous immunoglobulin preparation attenuates neurological signs in rat experimental autoimmune neuritis with the suppression of macrophage inflammatory protein -1α expression.
62
|
Kajii M...Kusunoki S
|
24262701 |
2014 |
| 42 |
Animal models of autoimmune neuropathy.
62
|
Soliven B
|
24615441 |
2014 |
| 43 |
Distinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background.
62
|
Bour-Jordan H...Bluestone JA
|
23850635 |
2013 |
| 44 |
[Unilateral optic neuritis and Miller Fisher syndrome].
62
|
Tabary A...Signolles C
|
23688610 |
2013 |
| 45 |
Chronic inflammatory demyelinating polyradiculoneuropathy.
62
|
Van den Bergh PY...Rajabally YA
|
23623582 |
2013 |
| 46 |
Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.
62
|
Querol L...Illa I
|
23280477 |
2013 |
| 47 |
Comparison of commercial tests for detecting multiple anti-ganglioside autoantibodies in patients with well-characterized immune-mediated peripheral neuropathies.
62
|
Caudie C...Fabien N
|
24409662 |
2013 |
| 48 |
Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.
62
|
Peltier AC...Donofrio PD
|
23117943 |
2012 |
| 49 |
Avian resistance to Campylobacter jejuni colonization is associated with an intestinal immunogene expression signature identified by mRNA sequencing.
62
|
Connell S...O'Farrelly C
|
22870198 |
2012 |
| 50 |
Advances in the diagnosis, pathogenesis and treatment of CIDP.
62
|
Dalakas MC...Medscape
|
21844897 |
2011 |
